Paul A. Bunn, Jr, MD, FASCO
Distinguished Professor
James Dudley Endowed Chair of Lung Cancer Research
Division of Medical Oncology
University of Colorado Cancer Center
University of Colorado, School of Medicine
Aurora, CO

Dr. Bunn is Distinguished Professor and the James Dudley Chair in Cancer Research in the Division of Medical Oncology at the University of Colorado Cancer Center of the University of Colorado School of Medicine in Aurora, CO, where he has practiced and taught since 1984.

Dr. Bunn received his BA from Amherst College in Amherst, MA, and received his MD from Weill Cornell Medical College in New York City, NY. He completed an internship and residency at the University of California San Francisco, San Francisco, CA and a fellowship in Medical Oncology at the National Cancer Institute (Bethesda) Program in Bethesda, MD. Dr. Bunn is Board Certified in Internal Medicine and Medical Oncology. He served as the Head of the Division of Medical Oncology from 1984-1992 and as the Director of the University of Colorado Cancer Center from 1986-2009. In the International Association for the Study of Lung Cancer, Dr. Bunn served on the Board of Directors from 1988 to 1994, president from 1997-2000, and CEO from 2004-2014. He was the president of the American Society of Clinical Oncology from 2002-2003.

The author of hundreds of articles, reviews, and book chapters, Dr. Bunn’s research is well known in the cancer world. He focuses primarily on novel therapies for lung cancer. Dr. Bunn has led numerous national and local trials regarding the treatment of lung cancer, and his findings are credited with setting standards in the treatment of the disease.

Dr. Bunn has researched new personalized therapies for lung cancer that cause fewer side effects than traditional, intravenous chemotherapy. He has also studied the genetics of the disease, seeking to learn how gene therapy could be used to combat the disease. Dr. Bunn is currently the Principal Investigator on the Specialized Program in Research Excellence in Lung Cancer (SPORE) grant funded by the National Institutes of Health and the National Cancer Institute that aims to expand understanding about the biology of the disease, as well as to find new methods of diagnosis, prevention, and treatment.